Table I.
Patients (n=50) | ||
---|---|---|
|
||
Characteristics | No. | % |
Age, years [median (range)] | 65 (44–78) | |
Gender | ||
Female | 17 | 34.0 |
Male | 33 | 66.0 |
ECOG PS | ||
0 | 24 | 48.0 |
1 | 26 | 52.0 |
Histology | ||
Adenocarcinoma | 29 | 58.0 |
Squamous cell carcinoma | 18 | 36.0 |
Large-cell carcinoma | 2 | 4.0 |
Adenosquamous cell carcinoma | 1 | 2.0 |
Clinical stage (TNM, version 6) | ||
IIIA | 1 | 2.0 |
IIIB | 15 | 30.0 |
IV | 32 | 64.0 |
Postoperative recurrence | 2 | 4.0 |
Courses of chemotherapy | ||
0 | 1 | 2.0 |
1 | 5 | 10.0 |
2 | 11 | 22.0 |
3 | 9 | 18.0 |
4 | 19 | 38.0 |
5 | 3 | 6.0 |
6 | 2 | 4.0 |
ECOG PS, Eastern Cooperative Oncology Group performance status; TNM, tumor-node-metastasis.